Shared genetic variants across substance use disorders implicate common neurobiological pathways, a genome‐wide mixed methods study
General Psychiatry · 2026-04 · 39 (2)
DOI: 10.1002/gps3.70017 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift General Psychiatry, online erschienen am 20.04.2026. Verfasst von Børge Holen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Precision Psychiatry Institute of Clinical Medicine University of Oslo Oslo Norway. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd, Helse Sør-Øst RHF, NordForsk.
Abstract (Originalsprache)
Background
Substance use disorders (SUDs) are highly heritable, but the extent of shared and distinct genetic architecture across different SUDs is unclear.
Aims
To compare the genetic architectures of alcohol use disorder (AUD), cannabis use disorder (CUD) and opioid use disorder (OUD) and to identify shared and unique genetic loci.
Methods
We analysed large‐scale genome‐wide association study (GWAS) summary statistics from individuals of European ancestry recruited in Europe and the USA. The mixture model MiXeR was used to estimate the unique genetic architecture characteristics of each SUD, including its polygenicity, single nucleotide polymorphism (SNP)‐heritability and discoverability, a measure of the distribution of genetic signal across all causal variants. Pairwise conditional/conjunctional false discovery rate (cond/conjFDR) analyses identified shared loci, followed by biological annotation of implicated genes.
Results
AUD demonstrated the highest polygenicity, followed by CUD and OUD. SNP‐based heritability was 0.10 for AUD and OUD and 0.01 for CUD. Discoverability was highest for OUD, followed by AUD and CUD. Currently, genome‐wide significant SNPs explain 2.0% of AUD, 0.3% of CUD and 0.2% of OUD variance. Cond/conjFDR identified 39 novel loci for AUD, 10 for CUD and 1 for OUD. Of implicated genes, most were expressed in the brain, including several involved in gamma‐aminobutyric acid and dopaminergic neurotransmission, opioid neurophysiology, myelination, DNA recombination, apoptosis and ubiquitin‐dependent protein catabolism.
Conclusions
SUDs have polygenic architectures with many shared loci and are similar with regards to some characteristics. However, the level of polygenicity differs across SUDs, with AUD being considerably more polygenic than OUD, whereas CUD is intermediate in terms of its polygenicity. The novel loci implicate genes primarily expressed in the brain, involving a variety of biological functions. The findings expand our view of the aetiology of these disorders, while supporting the hypothesis of a shared set of pleiotropic SUD genes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Precision Psychiatry Institute of Clinical Medicine University of Oslo Oslo Norway.
- Division of Mental Health and Addiction Oslo University Hospital Oslo Norway.
- INSERM UMR-S1144 Université Paris Cité Paris France.
- Department of Psychiatry Institute for Genomics in Health SUNY Downstate Health Sciences University Brooklyn New York USA.
- Department of Radiology University of California, San Diego La Jolla California USA.
- Multimodal Imaging Laboratory University of California, San Diego La Jolla California USA.
Förderung
- Norges Forskningsråd
- Helse Sør-Øst RHF
- NordForsk
- H2020 European Institute of Innovation and Technology
- Stiftelsen Kristian Gerhard Jebsen
- Universitetet i Oslo
- Foundation for the National Institutes of Health
Zitieren
APA
Holen, B., Rahman, Z., Shadrin, A. A., Icick, R., O'Connell, K. S., Rødevand, L., Parker, N., Tesfaye, M., Jaholkowski, P., Frei, O., Dale, A. M., Djurovic, S., Andreassen, O. A., & Smeland, O. B. (2026). Shared genetic variants across substance use disorders implicate common neurobiological pathways, a genome‐wide mixed methods study. General Psychiatry, 39(2). https://doi.org/10.1002/gps3.70017
Vancouver
Holen B, Rahman Z, Shadrin AA, Icick R, O'Connell KS, Rødevand L, et al. Shared genetic variants across substance use disorders implicate common neurobiological pathways, a genome‐wide mixed methods study. General Psychiatry. 2026;39(2). doi:10.1002/gps3.70017
BibTeX
@article{Holen2026,
author = {Holen, Børge and Rahman, Zillur and Shadrin, Alexey A and Icick, Romain and O'Connell, Kevin S and Rødevand, Linn and Parker, Nadine and Tesfaye, Markos and Jaholkowski, Piotr and Frei, Oleksandr and Dale, Anders M and Djurovic, Srdjan and Andreassen, Ole A and Smeland, Olav B},
title = {Shared genetic variants across substance use disorders implicate common neurobiological pathways, a genome‐wide mixed methods study},
journal = {General Psychiatry},
year = {2026},
volume = {39},
number = {2},
doi = {10.1002/gps3.70017}
}
EUVIMED